We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNRG:NASDAQHallador Energy Company Analysis

Data as of 2026-09-06 - not real-time

$16.60

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Hallador Energy Company trades at $16.60, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it gained 8.9%. RSI sits at 55.7, which reads as neutral, and MACD momentum is bullish. Price has been bracketed by support at $14.68 and resistance at $16.80.
Multiples put this in fair territory: 830.0 times earnings against the sector's 19.4. Analyst price targets sit 70.7% above the current price.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 52.0%, a beta of 1.46 and a maximum drawdown of 42.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against sell longer out, with 4/10 conviction on the long call.

Top Market Events

TERRE HAUTE, Ind. AP — TERRE HAUTE, Ind. AP — Hallador Energy Co. HNRG on Monday reported a loss of $15.2 million...Hallador Energy HNRG came out with a quarterly loss of $0.Hallador Energy Co HNRG reports a Q2 net loss but secures landmark capacity agreements and lowers Turtle Creek project...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading below the 200-day average of 17.74
  • MACD momentum is positive
  • 30-day price change of +8.9%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 830.0 versus sector average of 19.4
  • Trading below the 200-day average of 17.74
  • Analyst targets imply +70.7% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • P/E of 830.0 versus sector average of 19.4
  • Negative profit margin of -0.2%
  • Analyst targets imply +70.7% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin-0.20%
P/E Ratio830.0
ROE-0.58%
ROA2.06%
Debt/Equity25.07
P/B Ratio4.1
Op. Cash Flow$28.0M
Free Cash Flow$-5112625
Industry P/E19.4

Technical Analysis

TrendNeutral
RSI55.7
Support$14.68
Resistance$16.80
MA 20$16.08
MA 50$15.93
MA 200$17.74
MACDBullish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair Value$4.86
Target Price$28.33
Upside/Downside70.68%
GradeFair
TypeGrowth

Risk Assessment

Beta1.46
Volatility52.02%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.